These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3811978)

  • 1. Role of arginine-vasopressin for the development of hypertension following aortic constriction.
    Aperia A; Sahlgren B; Eklöf AC; Lundin S; Melin P
    Acta Physiol Scand; 1986 Dec; 128(4):495-9. PubMed ID: 3811978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
    Hinojosa C; Haywood JR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the renal component of the hypertension in rats with aortic constriction. Role of angiotensin II.
    Sahlgren B; Eklöf AC; Aperia A
    Acta Physiol Scand; 1986 Aug; 127(4):443-8. PubMed ID: 3529826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanical and neuro-humoral factors in acute aortic coarctation hypertension.
    Salgado HC; Fazan R; Machado BH; Salgado MC
    Agents Actions Suppl; 1992; 36():152-63. PubMed ID: 1609637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of arginine-8-vasopressin and 1-deamino-8-D-arginine-vasopressin on ACTH secretion in rats.
    László FA; Janáky T; Julesz J; Kárteszi M; Makara GB; Stark E
    Endocrinol Exp; 1983 Jun; 17(2):133-6. PubMed ID: 6309504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant hypertension in Brattleboro (vasopressin-deficient) rats.
    Woods RL; Abrahams JM; Kincaid-Smith P; Johnston CI
    J Hypertens; 1983 Jun; 1(1):37-43. PubMed ID: 6397512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertensive response to acute aortic coarctation in chronic vasopressin deficient states.
    Fregoneze JB; Salgado MC; Castro e Silva EJ; Salgado HC
    Clin Exp Hypertens; 1995 Aug; 17(6):977-88. PubMed ID: 7581264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of subcutaneous administration of arginine-8-vasopressin on the electroencephalogram of conscious rats are mediated by peripheral vasopressin V1 receptors.
    Ebenezer IS
    Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):315-21. PubMed ID: 7934310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroosmotic activities of arginine-vasopressins modified either in positions 1, 2 and 4 or at N-terminal extensions.
    Bakos P; Shakhmatova EI; Ponec J; Alexandrová M; Lichardus B; Lammek B; Rekowski P; Kupryszewski G
    Gen Physiol Biophys; 1992 Aug; 11(4):359-76. PubMed ID: 1426981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between arginine vasopressin and angiotensin II receptors in the central regulation of sodium balance.
    Saad WA; Camargo LA; Antunes-Rodrigues J; Saad WA; Guarda IF; Guarda RS
    Regul Pept; 2005 Dec; 132(1-3):53-8. PubMed ID: 16198010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of renal prostaglandin synthesis by the pressor activity of vasopressin.
    Zipser RD; Myers SI; Needleman P
    Endocrinology; 1981 Feb; 108(2):495-9. PubMed ID: 6893820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine vasopressin as an intragonadal hormone in Brattleboro rats: presence of a testicular vasopressin-like peptide and functional vasopressin receptors.
    Kasson BG; Hsueh AJ
    Endocrinology; 1986 Jan; 118(1):23-31. PubMed ID: 3000735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of vascular and tubular effects of arginine-vasopressin to the development of deoxycorticosterone acetate (DOCA)-salt hypertension in rats.
    Hofbauer KG; Mah SC; Wood JM; Baum HP; Hänni H; Opperman JR; Kraetz J
    J Hypertens Suppl; 1984 Dec; 2(3):S333-5. PubMed ID: 6599676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of arginine-vasopressin for pineal melatonin synthesis in the rat: involvement of vasopressinergic receptors.
    Stehle J; Reuss S; Riemann R; Seidel A; Vollrath L
    Neurosci Lett; 1991 Feb; 123(1):131-4. PubMed ID: 1829510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin reduces release from vasopressin-neurons and oxytocin-neurons by acting on V2-like receptors.
    Cheng SW; North WG
    Brain Res; 1989 Feb; 479(1):35-9. PubMed ID: 2522339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin: mechanism of central cardiovascular action in conscious rats.
    Rohmeiss P; Becker H; Dietrich R; Luft F; Unger T
    J Cardiovasc Pharmacol; 1986; 8(4):689-96. PubMed ID: 2427805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic AVP deficiency abolishes cold-induced diuresis but does not attenuate cold-induced hypertension.
    Sun Z
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1472-7. PubMed ID: 16396942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of arginine vasopressin in regulation of systemic arterial pressure.
    Rossi NF; Schrier RW
    Annu Rev Med; 1986; 37():13-20. PubMed ID: 3518603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of angiotensin and vasopressin V(1) receptors on water and sodium intake induced by injection of vasopressin into lateral septal area.
    Mima EG; Andrade RR; Camargo LA; Saad WA
    Regul Pept; 2004 May; 118(3):159-64. PubMed ID: 15003832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.